Health Care: Drugs

Coherus BioSciences Inc (CHRS: NASDAQ)

$14.33 n/a | n/a%
02/05/16 - 03:59 PM ET
Company Cash Flow
Dec 2014 Dec 2013
Cash Flow From Operating Activities
Net Income (Loss) -87.18M -53.63M
Operating Gains/Losses -2.05M 0.00
Extraordinary Gains / Losses 0.00 0.00
(Increase) Decrease In Receivables -1.71M -104.00K
(Increase) Decrease in Inventories 0.00 0.00
(Increase) Decrease In Other Current Assets -2.05M 60.00K
(Decrease) Increase In Payables 3.63M -386.00K
(Decrease) Increase In Other Current Liabilities 3.95M 2.85M
(Increase) Decrease In Other Working Capital 39.30M 42.28M
Other Non-Cash Items 32.29M 27.24M
Net Cash From Continuing Operations -23.93M 15.42M
Net Cash From Discontinued Operations 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -23.93M 15.42M
Sale of Property, Plant & Equipment 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00
Purchases of Property, Plant & Equipment -2.85M -373.00K
Acquisitions 2.33M 0.00
Purchases of Short-Term Investments 0.00 0.00
Other Cash from Investing Activities -10.00K 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -525.00K -373.00K
Issuance of Debt 0.00 9.95M
Cash Used for Financing Activities
Issuance of Capital Stock 140.26M 6.00K
Repayment of Long-Term Debt 0.00 0.00
Repurchase of Capital Stock -2.00K 0.00
Payment of Cash Dividends 0.00 0.00
Other Financing Charges, Net -4.31M 0.00
Net Cash From Financing Activities 135.96M 9.96M
Effect of Exchange Rate Changes -666.00K 0.00
Net Change in Cash & Cash Equivalents 110.84M 25.01M

Portfolios with CHRS

Latest CHRS Headlines from TheStreet

More Financial News for CHRS

Press Releases for CHRS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter